Patent details
EP1901770 Title: GH AND IGF-1 FOR TREATMENT OF GROWTH DISORDERS
Basic Information
- Publication number:
- EP1901770
- PCT Application Number:
- PCT/US/2006/021282
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP067845297
- PCT Publication Number:
- WO/2006/130769
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- GH AND IGF-1 FOR TREATMENT OF GROWTH DISORDERS
- French Title of Invention:
- UTILISATION DE L'HORMONE DE CROISSANCE ET DE L'IGF-1 POUR TRAITER LES TROUBLES DE LA CROISSANCE
- German Title of Invention:
- WACHSTUMSHORMONE UND IGF-1 ZUR BEHANDLUNG VON WACHSTUMSSTÖRUNGEN
- SPC Number:
Dates
- Filing date:
- 01/06/2006
- Grant date:
- 24/12/2014
- EP Publication Date:
- 24/12/2014
- PCT Publication Date:
- 07/12/2006
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 26/03/2008
- EP B1 Publication Date:
- 24/12/2014
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 01/06/2015
- Expiration date:
- 01/06/2026
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 07/02/2015
- Name:
- Ipsen Biopharmaceuticals Inc.
- Address:
- 106 Allen Road, 3rd Floor, Basking Ridge, NJ 07920, United States (US)
Inventor
- Name:
- CLARK Ross G.
- Address:
- New Zealand (NZ)
Priority
- Priority Number:
- 687617 P
- Priority Date:
- 02/06/2005
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- C07K 14/65;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|